Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Hospet Circle, Vijaynagar, Karnataka. The suspension applies to a store located at Basaveshwara Nagar, Karnataka for a period of two days. The order was received on May 12, 2026. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company has disclosed a potential revenue loss of Rs 0.76 lakh due to this suspension.
The impact appears minimal as it involves only one store out of the company's pharmacy network, with a small quantified revenue loss of Rs 0.76 lakh. However, any regulatory action against a pharmacy chain can raise concerns about compliance standards.